Neuropathic Pain clinical trials

Explore recruiting neuropathic pain clinical trials.

Recruiting neuropathic pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neuropathic Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Short-term effectiveness of Gabapentin versus Placebo in acute Lumbosacral Radiculalgia by herniation disc: a prospective, multicentric, randomized, controlled, double-blind study (GRADE)

France

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled 2-way crossover study to assess the analgesic effects of THC in patients with chronic neuropathic pain and to phenotype the responders to THC treatment.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE I, COMBINED STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SZV-1287 IN HEALTHY MALE VOLUNTEERS AFTER SINGLE ASCENDING AND MULTIPLE ASCENDING ORAL DOSES FOR 7 DAYS

Hungary

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, 12-month Phase 3 Study to Evaluate the Effect of Venglustat on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age with Fabry Disease who are treatment-naïve or Untreated for at Least 6 Months

Norway, Poland, France, Romania, Italy, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double-blind, randomized 2 arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate or severe chronic neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Germany, Bulgaria, Spain, Hungary, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 3 confirmatory, randomised 1:1 double-blind, placebo-controlled study evaluating the analgesic efficacy of capsaicin 8% patches in chronic coccygodynia. CAPSACOX Study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neuropathic Pain trials by city

Neuropathic Pain in Toronto Neuropathic Pain in Vancouver Neuropathic Pain in Montreal Neuropathic Pain in Calgary Neuropathic Pain in Edmonton Neuropathic Pain in Ottawa Neuropathic Pain in Winnipeg Neuropathic Pain in Quebec City Neuropathic Pain in Hamilton Neuropathic Pain in Kitchener Neuropathic Pain in London Neuropathic Pain in Halifax Neuropathic Pain in New York Neuropathic Pain in Los Angeles Neuropathic Pain in Chicago Neuropathic Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease